CStone Pharmaceuticals ('CStone', HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of anti-cancer therapies, today announced that the first patient ...

In The Lancet Hematology, Jorge E Cortes and colleagues1 report a phase 1/2 study on vodobatinib in patients with resistance ...

'We're one of the fastest growing skincare brands in the world and a top five skincare brand in every single market - ...

Boostaro is a new blood flow support supplement and has received positive feedback and attention from users and experts. The ...

Intensifying oral diuretic therapy was linked to worse prognosis, but not everybody is sold on its use an endpoint.

Newsom also offered to help find a mutually agreeable mediator, as he did during the Northern California strike in 2022, when ...

You can fix your eyes, your nose, get injections for crow’s feet, but the neck often gives away your age. As we age, our necks can make us look older. That loose skin around the neck area is ...

A clinical trial to test the effectiveness of a new, plant-based oral drug to treat type 2 diabetes has produced some ...

Fresenius Kabi, an operating company of Fresenius, and Formycon AG, a leading, independent developer of high-quality ...

New product expected to set a new standard for potency and performance in the estimated $20 billon pre-workout marketDesert Stream Inc., a ...

Y-mAbs Therapeutics, Inc. (the "Company” or "Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and ...

The current model for managing chronic obstructive pulmonary disease (COPD) generally considers inhalers from the same therapeutic class to be clinically equivalent.1 When a long-acting muscarinic ...